This four-wave tracker study, commissioned by a leading pharmaceutical company, explored doctors' perceptions on treating interconnected conditions such as type 2 diabetes, chronic kidney disease, and chronic heart failure. We navigated tight timelines, holiday-season challenges, and delivered hard-to-reach specialties, successfully recruiting 1,551 respondents from family medicine, endocrinology, cardiology, nephrology, and internal medicine.

This project marks the sixth wave of a longitudinal study, launched in 2023, focused on the treatment landscape of myelofibrosis. The survey identifies unmet needs, including anaemia management, transfusion dependency, and the gap in third-line therapies. It also examines prescribing trends, product performance (e.g., JAK inhibitors), and potential differences between European markets and Japan. QQFS successfully recruited participants and delivered high-quality data, ensuring continuity and client satisfaction.

Explore how QQFS achieved remarkable outcomes in recruiting cancer treatment specialists across multiple countries (Japan, China, US, UK, and France) for an online quantitative survey spanning six months. Discover how our efficient recruitment process and high-quality translations impressed the client, showcasing our ability to meet their needs in diverse markets.

Discover how QQFS's efficiently conducting a multi-wave online quantitative tracker study among dentists in Japan, Spain, and Canada, with a primary focus on dental products. Uncover how we achieved remarkable outcomes, including top-tier satisfaction scores and precise sample delivery across all three markets, even overcoming challenges in Japan.